{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:23:20Z","timestamp":1648675400133},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1989,8,1]],"date-time":"1989-08-01T00:00:00Z","timestamp":617932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ital J Neuro Sci"],"published-print":{"date-parts":[[1989,8]]},"DOI":"10.1007\/bf02334944","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T22:07:51Z","timestamp":1142374071000},"page":"399-403","source":"Crossref","is-referenced-by-count":6,"title":["Pineal melatonin and sensory symptoms in Parkinson disease"],"prefix":"10.1007","volume":"10","author":[{"given":"R.","family":"Sandyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02334944_CR1","first-page":"30","volume":"6","author":"Y. Agid","year":"1985","unstructured":"Agid Y., Javoy-Agid F.:Peptides and Parkinson's disease. TINS, 6: 30\u201335, 1985.","journal-title":"TINS"},{"key":"BF02334944_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00207458508985598","volume":"26","author":"M. Aldegunde","year":"1985","unstructured":"Aldegunde M., Miguez I., Veira J.:Effects of pinealectomy on regional brain serotonin metabolism. Inter. J. Neurosci, 26: 9\u201313, 1985.","journal-title":"Inter. J. Neurosci"},{"key":"BF02334944_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.162.3850.277","volume":"162","author":"F. Anton-Tay","year":"1968","unstructured":"Anton-Tay F., Chou C., Anton S., Wurtman R. J.:Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science, 162:277\u2013278, 1968.","journal-title":"Science"},{"key":"BF02334944_CR4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0024-3205(71)90155-X","volume":"10","author":"F. Anton-Tay","year":"1971","unstructured":"Anton-Tay F., Diaz J.L., Fernandez-Guardiola A.:On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sci., 10:841\u2013850, 1971.","journal-title":"Life Sci."},{"key":"BF02334944_CR5","first-page":"315","volume-title":"Advances in Biochemical Psychopharmacology","author":"F. Anton-Tay","year":"1974","unstructured":"Anton-Tay F.:Melatonin: effect on brain functions. In: Advances in Biochemical Psychopharmacology. Costa E., Gessa G.L., Sandler M. (eds), New York, Raven Press, 11:315\u2013324, 1974."},{"key":"BF02334944_CR6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp.48.12.1240","volume":"49","author":"M.C.P. Apps","year":"1985","unstructured":"Apps M.C.P., Sheaff P.C., Ingram D.A., et al:Respiration and sleep in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry., 49:1240\u20131245, 1985.","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"BF02334944_CR7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1073\/pnas.62.2.544","volume":"62","author":"J. Axelrod","year":"1968","unstructured":"Axelrod J., Shein H.M., Wuetman R.J.:Stimulation of c24-melatonin synthesis from c14 tryptopahn by noradrenaline in rat pineal in organ culture. Proc. Natl. Acad. Sci. USA. 62:544\u2013549, 1968.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BF02334944_CR8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1176\/ajp.142.7.811","volume":"142","author":"R. Brown","year":"1985","unstructured":"Brown R., Kocsis J.H., Caroff S. et al:Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am. J. Psychiatry., 142:811\u2013816, 1985.","journal-title":"Am. J. Psychiatry."},{"key":"BF02334944_CR9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0014-4886(77)90014-0","volume":"55","author":"T.E. Burks","year":"1977","unstructured":"Burks T.E., Dafny N.:Morphine and 5-hydroxytryptamine interaction in rat hypothalamus and pineal body. Exp. Neurol., 55:458\u2013450, 1977.","journal-title":"Exp. Neurol."},{"key":"BF02334944_CR10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archneur.1988.00520330051010","volume":"45","author":"M. Cantello","year":"1988","unstructured":"Cantello M., Gilli M., et al:Analgesic action of methylphenidate on parkinsonian sensory symptoms. Mechanisms and pathophysiological implications. Arch. Neurol., 45:973\u2013976, 1988.","journal-title":"Arch. Neurol."},{"key":"BF02334944_CR11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1126\/science.173.3995.450","volume":"173","author":"G.C. Cotzias","year":"1971","unstructured":"Cotzias G.C., Tang L.C., Miller S.T. et al:Melatonin and abnormal movements induced by L-dopa in mice. Science, 173:450\u2013452, 1971.","journal-title":"Science"},{"key":"BF02334944_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3171\/jns.1985.63.3.0321","volume":"63","author":"S.S. Erlich","year":"1985","unstructured":"Erlich S.S., Apuzzo L.J.:The pineal gland: anatomy, physiology, and clinical significance. J. Neurosurg. 63:321\u2013341, 1985.","journal-title":"J. Neurosurg."},{"key":"BF02334944_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-079X.1988.tb00766.x","volume":"5","author":"D. Esposti","year":"1988","unstructured":"Esposti D., Esposti E., Lissoni P. et al:Action of morphine on melatonin release in the rat. J. Pineal Res., 5:35\u201339, 1988.","journal-title":"J. Pineal Res."},{"key":"BF02334944_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00688674","volume":"34","author":"L.S. Forno","year":"1976","unstructured":"Forno L.S., Norville R.L.:Ultrastructure of Lewy bodies in stellate ganglia. Acta Neurophatol., 34:183\u2013197, 1976.","journal-title":"Acta Neurophatol."},{"key":"BF02334944_CR15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/WNL.25.9.861","volume":"25","author":"S. Fahn","year":"1985","unstructured":"Fahn S., Snider S.R., Prasad A.L. et al:Normalization of brain serotonin in levodopa-treated rats by L-trytophan. Neurology 25:861\u2013865, 1985.","journal-title":"Neurology"},{"key":"BF02334944_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0304-3940(81)90452-3","volume":"27","author":"M. Geggard","year":"1981","unstructured":"Geggard M., Gaffori O., Chaveay J. et al.:Dramatic increase in pineal gland melatonin levels in the rat after subcutaneous injection of des-tyrosine gamma-endorphin. Neurosci. Lett. 27:329\u2013334, 1981.","journal-title":"Neurosci. Lett."},{"key":"BF02334944_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.870010106","volume":"1","author":"C.G. Goetz","year":"1986","unstructured":"Goetz C.G., Tanner C.M., Levy M. et al:Pain in Parkinson's disease. Movement Disorders, 1:45\u201349, 1986.","journal-title":"Movement Disorders"},{"key":"BF02334944_CR18","first-page":"100P","volume":"24","author":"R. Harthley","year":"1972","unstructured":"Harthley R., Padwick D., Smith J.S.:The inhibition of pineal hydroxyindole-omethyltransferase by haloperidol and fluphenazine. J. Pharm. Pharmac. 24:100P-103P, 1972.","journal-title":"J. Pharm. Pharmac."},{"key":"BF02334944_CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/jcem-55-1-27","volume":"55","author":"H. Iguchi","year":"1982","unstructured":"Iguchi H., Kato H., Ibayashi H.:Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J. Clin. Endocrinol. Metab., 55:27\u201329, 1982.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF02334944_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt1971122part2397","volume":"4","author":"A. Kales","year":"1971","unstructured":"Kales A., Ansel R.D., Markham C.H. et al:Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin. Pharmacol & Therap. 4:397\u2013406, 1971.","journal-title":"Clin. Pharmacol & Therap."},{"key":"BF02334944_CR21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/endo-91-5-1323","volume":"91","author":"A.J. Kastin","year":"1972","unstructured":"Kastin A.J., Viosca S., Nair R.M.G. et al:Interactions between pineal, hypothalamus and pituitary involving melatonin, MSH release-inhibiting factor and MSH. Endocrinology, 91:1323\u20131328, 1972.","journal-title":"Endocrinology"},{"key":"BF02334944_CR22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0196-9781(82)90170-X","volume":"3","author":"M. Kavaliers","year":"1982","unstructured":"Kavaliers M.:Pineal mediation of the thermoregulatory and behavioral activating effects of beta-endorphin. Peptides, 3:679\u2013685, 1982.","journal-title":"Peptides"},{"key":"BF02334944_CR23","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/0024-3205(83)90427-7","volume":"32","author":"M. Kavaliers","year":"1983","unstructured":"Kavaliers M., Hirst M., Teskey G.C.:Ageing, opioid analgesia and the pineal gland. Life Sci., 32:2279\u20132551, 1983.","journal-title":"Life Sci."},{"key":"BF02334944_CR24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0361-9230(83)90033-3","volume":"10","author":"D.C. Klein","year":"1983","unstructured":"Klein D.C., Smoot R., Weller J.L. et al:Lesions of the paraventricular nucleus area for the hypothalamus disrupt the suprachiasmatic \u2014 spinal cord circuit in the melatonin rhythm generating systems. Brain Res. Bull. 10:647\u2013652, 1983.","journal-title":"Brain Res. Bull."},{"key":"BF02334944_CR25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.34.7.957","volume":"34","author":"W.C. Koller","year":"1985","unstructured":"Koller W.C.:Sensory symptoms in Parkinson's disease. Neurology. 34:957\u2013959, 1985.","journal-title":"Neurology."},{"key":"BF02334944_CR26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000123350","volume":"35","author":"M.S.A. Kumar","year":"1982","unstructured":"Kumar M.S.A., Chen C.L., Sharp D.C. et al:Diurnal fluctuations in methionine-enkephalin levels in the hypothalamus and preoptic area of the male rat: effects of pinealectomy. Neuroendocrinology, 35:28\u201331, 1982.","journal-title":"Neuroendocrinology"},{"key":"BF02334944_CR27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-079X.1984.tb00211.x","volume":"1","author":"M.S.A. Kumar","year":"1984","unstructured":"Kumar M.S.A., Besch E.L., Millard W.J., Sharp D.C., Leadem C.A.:Effect of short photoperiod on hypothalamic methionine-enkephalin and LHRH content and serum beta-endorphin-like immunoreactivity (beta-end LI) levels in golden hamsters. J. Pineal Res., 1:197\u2013205, 1984.","journal-title":"J. Pineal Res."},{"key":"BF02334944_CR28","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/0024-3205(81)90710-4","volume":"29","author":"M.L. Lakin","year":"1981","unstructured":"Lakin M.L., Miller C.H., Statt M.L., Winters W.D.:Involvement of the pineal gland and melatonin in murine analgesia. Life Sci. 29:2543, 1981.","journal-title":"Life Sci."},{"key":"BF02334944_CR29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ana.410030207","volume":"3","author":"J.W. Langston","year":"1978","unstructured":"Langston J.W., Forno L.S.:The hypotholamus in Parkinsons disease. Ann. Neurol. 3:129\u2013133, 1978.","journal-title":"Ann. Neurol."},{"key":"BF02334944_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.0954-6820.1973.tb19428.x","volume":"194","author":"J. Lehmann","year":"1973","unstructured":"Lehmann J.:Tryptophan malabsorption in levodopa-treated parkinsonian patients. Acta Med. Scand. 194:181\u2013189, 1973.","journal-title":"Acta Med. Scand."},{"key":"BF02334944_CR31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01249612","volume":"65","author":"P. Lissoni","year":"1986","unstructured":"Lissoni P., Esposti D., Esposti G. et al:A clinical study on the relationship between the pineal gland and the opioid system. J. Neural Transmission 65:63\u201373, 1986.","journal-title":"J. Neural Transmission"},{"key":"BF02334944_CR32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(84)90598-3","volume":"98","author":"P.R. Lowenstein","year":"1984","unstructured":"Lowenstein P.R., Pereyra E.N., Solveyra C.G. et al:Effect of naloxone on the nocturnal rise of rat pineal melatonin content. Eur. J. Pharmacol, 98:261\u2013264, 1984.","journal-title":"Eur. J. Pharmacol"},{"key":"BF02334944_CR33","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","volume":"34","author":"R. Mayeux","year":"1984","unstructured":"Mayeux R., Stern Y., Cote L., Williams J.B.W.:Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology, 34:642\u2013646, 1984.","journal-title":"Neurology"},{"key":"BF02334944_CR34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/ajp.143.6.756","volume":"143","author":"R. Mayeux","year":"1986","unstructured":"Mayeux R., Stern Y., Williams J.B.W. et al:Clinical and biochemical features of depression in Parkinson's disease. Am. J. Psychiatry, 143:756\u2013759, 1986.","journal-title":"Am. J. Psychiatry"},{"key":"BF02334944_CR35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-0327(87)90028-0","volume":"12","author":"I.M. McIintyre","year":"1987","unstructured":"McIintyre I.M., Norman T.R., Marriott P.F., Burrows G.D.:The pineal hormone melatonin in panic disorder. J. Affective Disord., 12:203\u2013206, 1987.","journal-title":"J. Affective Disord."},{"key":"BF02334944_CR36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0006-3223(88)90291-0","volume":"23","author":"A. Miles","year":"1988","unstructured":"Miles A., Philbrick D.R.S.:Melatonin and Psychiatry. Biol. Psychiatry, 23:405\u2013425, 1988.","journal-title":"Biol. Psychiatry"},{"key":"BF02334944_CR37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp.33.2.188","volume":"33","author":"R.H.S. Mindham","year":"1970","unstructured":"Mindham R.H.S.:Psychiatric symptoms in parkinsonism. J. Neurol. Neurosurg Psychiatry, 33:188\u2013191, 1970.","journal-title":"J. Neurol. Neurosurg Psychiatry"},{"key":"BF02334944_CR38","first-page":"208P","volume":"36","author":"R.J. Naylor","year":"1969","unstructured":"Naylor R.J., Olley J.E.:The distribution of haloperidol in the rat brain. Br. J. Pharmacol., 36:208P-209P, 1969.","journal-title":"Br. J. Pharmacol."},{"key":"BF02334944_CR39","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/WNL.35.9.1371","volume":"35","author":"G. Nappi","year":"1985","unstructured":"Nappi G., Petraglia F., Martignoni E. et al:Beta-endorphin cerebrospinal fluid decrease in untreated parkinsonian patients. Neurology., 35:1371\u20131374, 1985.","journal-title":"Neurology."},{"key":"BF02334944_CR40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(84)92924-6","volume":"2","author":"J.G. Nutt","year":"1984","unstructured":"Nutt J.G., Carter J.H.:Sensory symptoms in parkinsonism related to central deopaminergic dysfunction. Lancet, 2:456\u2013457, 1984.","journal-title":"Lancet"},{"key":"BF02334944_CR41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(85)80069-0","volume":"54","author":"L. Pique","year":"1985","unstructured":"Pique L., Jegou S., Bertagna X. et al:Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients. Neurosci. Lett., 54:141\u2013146, 1985.","journal-title":"Neurosci. Lett."},{"key":"BF02334944_CR42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02017891","volume":"9","author":"I. Rainero","year":"1988","unstructured":"Rainero I., Pinessi L.:Alpha-MSH and Parkinson disease. Ital. J. Neurol. Sci., 9:95\u201396, 1988.","journal-title":"Ital. J. Neurol. Sci."},{"key":"BF02334944_CR43","first-page":"163","volume":"19","author":"U.K. Rinne","year":"1983","unstructured":"Rinne U.K., Rinne J.K., Laakso K. et al:Brain enkephalin receptors in Parkinson's disease. J. Neural Transmission., 19:163\u2013171, 1983.","journal-title":"J. Neural Transmission."},{"key":"BF02334944_CR44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-079X.1986.tb00760.x","volume":"3","author":"R.L. Sack","year":"1986","unstructured":"Sack R.L., Lewy A.J., Erb D.L. et al:Human melatonin production decreases with age. J. Pineal Res., 3:379\u2013388, 1986.","journal-title":"J. Pineal Res."},{"key":"BF02334944_CR45","first-page":"3","volume":"61","author":"R. Sandyk","year":"1982","unstructured":"Sandyk R.:Backache as an early symptom in Parkinson's disease. S. Afr. Med. J., 61:3\u20139, 1982.","journal-title":"S. Afr. Med. J."},{"key":"BF02334944_CR46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.35.4.619-b","volume":"35","author":"R. Sandyk","year":"1985","unstructured":"Sandyk R., Snider S.R.:Sensory symptoms in Parkinson's disease. Neurology., 35:619\u2013620, 1985.","journal-title":"Neurology."},{"key":"BF02334944_CR47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/pgmj.62.730.749","volume":"62","author":"R. Sandyk","year":"1986","unstructured":"Sandyk R.:Anticholinergic-induced analgesia: possible role for the cholinergic system in abnormal sensory symptoms in Parkinson's disease. Post Grad. Med. J., 62:749\u2013751, 1986.","journal-title":"Post Grad. Med. J."},{"key":"BF02334944_CR48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02337479","volume":"8","author":"R. Sandyk","year":"1987","unstructured":"Sandyk R., Iacono R.P., Bamford C.R.:The hypothalamus in Parkinsons disease. Ital. J. Neurol. Sci., 8:227\u2013234, 1987.","journal-title":"Ital. J. Neurol. Sci."},{"key":"BF02334944_CR49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00207458809000489","volume":"38","author":"R. Sandyk","year":"1988","unstructured":"Sandyk R., Iacono R.P., Bamford C.R.:Spinal cord mechanisms in amitryptyline responsive restless legs syndrome in Parkinson's disease. Inter. J. Neurosci., 38:121\u2013124, 1988.","journal-title":"Inter. J. Neurosci."},{"key":"BF02334944_CR50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00207458808985688","volume":"39","author":"R. Sandyk","year":"1988","unstructured":"Sandyk R., Bamford C.F., Iacono R.P.:Pain and sensory symptoms in Parkinson's disease. Inter. J. Neurosci., 39:15\u201325, 1988.","journal-title":"Inter. J. Neurosci."},{"key":"BF02334944_CR51","first-page":"147","volume":"9","author":"R. Sandyk","year":"1989","unstructured":"Sandyk R.:Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system. Inter. J. Neurosci., 9:147\u2013148, 1989.","journal-title":"Inter. J. Neurosci."},{"key":"BF02334944_CR52","unstructured":"Sandyk R., Fisher H.:Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. J. Clin. Psychopharmacol (in press)."},{"key":"BF02334944_CR53","doi-asserted-by":"crossref","unstructured":"Sandyk R., Fisher H.:Melatonin potentiates the effects of naloxone on reserpine-induced catalepsy in the rat. Inter. J. Neurosci. (in press).","DOI":"10.3109\/00207458909002156"},{"key":"BF02334944_CR54","first-page":"443","volume-title":"Advances in Neurology","author":"J. Santamaria","year":"1986","unstructured":"Santamaria J., Tolosa E.S., Valles A. et al:Mental depression in untreated Parkinson's disease of recent onset. In: Advances in Neurology. M.D. Yahr, K.J. Bergman (eds), Raven Press, New York, 45:443\u2013446, 1986."},{"key":"BF02334944_CR55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(86)91446-0","volume":"380","author":"B. Scatton","year":"1986","unstructured":"Scatton B., Dennis T., L'heureux R. et al:Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients. Brain Res., 380:181\u2013185, 1986.","journal-title":"Brain Res."},{"key":"BF02334944_CR56","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1176\/ajp.145.8.1020","volume":"145","author":"R.B. Schiffer","year":"1988","unstructured":"Schiffer R.B., Kurlan R., Rubin A., Boer S.:Evidence for atypical depression in Parkinson's disease. Am. J. Psychiatry, 145:1020\u20131022, 1988.","journal-title":"Am. J. Psychiatry"},{"key":"BF02334944_CR57","first-page":"2897","volume":"44","author":"J. Sigwald","year":"1968","unstructured":"Sigwald J., Ramondeaud C.:Les reactions desagreables ou douloureuses neuroleptique (paresthesies, impatiences, cramps, akathisie). Leur ameliration par l'alimenazine. Sem. Hop. Paris, 44:2897\u20132899, 1968.","journal-title":"Sem. Hop. Paris"},{"key":"BF02334944_CR58","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.26.5.423","volume":"26","author":"S.R. Snider","year":"1976","unstructured":"Snider S.R., Fahn S., Isgreen W.P., Cote L.J.:Primary sensory symptoms in parkinsonism. Neurology, 26:423\u2013429, 1976.","journal-title":"Neurology"},{"key":"BF02334944_CR59","first-page":"171","volume-title":"Handbook of Parkinson's disease","author":"S.R. Snider","year":"1987","unstructured":"Snider S.R., Sandyk R.:Sensory dysfunction. In: Handbook of Parkinson's disease, William C. Koller (ed), Marcel Dekker Inc. New York, pp. 171\u2013180, 1987."},{"key":"BF02334944_CR60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF00181962","volume":"95","author":"E. Souetre","year":"1988","unstructured":"Souetre E., Salvati E., Belugou J.L. et al:Antidepressant effect of 5-methoxypsoralen: a preliminary report. Psychopharmacology, 95:430\u2013431, 1988.","journal-title":"Psychopharmacology"},{"key":"BF02334944_CR61","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1471-4159.1979.tb11105.x","volume":"32","author":"D. Sugden","year":"1979","unstructured":"Sugden D., Morris R.D.:Changes in regional brain levels of tryptophan, 5-hydroxytryptamine, 5-hydroxyindoleacetic acid, dopamine and noradrenaline after pinealectomy in the rat. J. Neurochem., 32:1593\u20131594, 1979.","journal-title":"J. Neurochem."},{"key":"BF02334944_CR62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1212\/WNL.26.4.305","volume":"26","author":"R.D. Sweet","year":"1976","unstructured":"Sweet R.D., McDowell F.H., Feigenson J.S. et al:Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology, 26:305\u2013310, 1976.","journal-title":"Neurology"},{"key":"BF02334944_CR63","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/jcem-53-3-607","volume":"53","author":"M. Tetsuo","year":"1982","unstructured":"Tetsuo M., Polinsky R.J., Markey S.P., Kopin U.J.:Urinary 6-hydroxymelatonin excretion in patients with orthostatic hypotension. J. Clin. Endocrinol. Metab., 53:607\u2013610, 1982.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF02334944_CR64","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410200204","volume":"20","author":"G.R. Uhl","year":"1986","unstructured":"Uhl G.R., Hackney G.O., Torchia M. et al:Parkinson's disease: Nigral receptor changes support peptidergic role in nigrostriatal. Ann. Neurol. 20:194\u2013203, 1986.","journal-title":"Ann. Neurol."},{"key":"BF02334944_CR65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0024-3205(80)90019-3","volume":"27","author":"O Vuolteenaho","year":"1980","unstructured":"Vuolteenaho O, Vakkuri O., Leppaluoto J.:Wide distribution of beta-endorphin like immunoreactivity in extrapituitary tissues of rat. Life Sci., 27:57\u201362, 1980.","journal-title":"Life Sci."},{"key":"BF02334944_CR66","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(79)92837-X","volume":"2","author":"L. Wetterberg","year":"1979","unstructured":"Wetterberg L., Beck-Friis J., Aperia B., Petterson V.:Melatonin\/cortisol ratio in depression. Lancet, 2:1361, 1979.","journal-title":"Lancet"},{"key":"BF02334944_CR67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1176\/ajp.142.7.811","volume":"142","author":"R. Wetterberg","year":"1985","unstructured":"Wetterberg R., Kocsis J.H., Caroff S. et al:Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am. J. Psychiatry. 142:811\u2013816, 1985.","journal-title":"Am. J. Psychiatry."}],"container-title":["The Italian Journal of Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02334944.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02334944\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02334944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T20:58:29Z","timestamp":1557953909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02334944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,8]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,8]]}},"alternative-id":["BF02334944"],"URL":"https:\/\/doi.org\/10.1007\/bf02334944","relation":{},"ISSN":["0392-0461","1590-3478"],"issn-type":[{"value":"0392-0461","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,8]]}}}